Cargando…

Angiotensin II type 1 and type 2 receptor expression in circulating monocytes of diabetic and hypercholesterolemic patients over 3-month rosuvastatin treatment

BACKGROUND: In diabetes, a variety of pro-inflammatory cellular changes has been found in various cell types, including monocytes which are known to be involved in all the phases of atherogenesis. Angiotensin II (Ang II) type 1 receptor (AT(1)R) mediates the pro-atherogenic effects of Ang II whereas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marino, Franca, Maresca, Andrea Maria, Cosentino, Marco, Castiglioni, Luana, Rasini, Emanuela, Mongiardi, Christian, Maio, Ramona C, Legnaro, Massimiliano, Schembri, Laura, Dentali, Francesco, Grandi, Anna Maria, Guasti, Luigina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3549933/ https://www.ncbi.nlm.nih.gov/pubmed/23259529 http://dx.doi.org/10.1186/1475-2840-11-153

Ejemplares similares

Simvastatin down-regulates the production of Interleukin-8 by neutrophil leukocytes from dyslipidemic patients
por: Marino, Franca, et al.
Publicado: (2014)

Relationship between regulatory T cells subsets and lipid profile in dyslipidemic patients: a longitudinal study during atorvastatin treatment
por: Guasti, Luigina, et al.
Publicado: (2016)

Gene Expression of Adhesion Molecules in Endothelial Cells from Patients with Peripheral Arterial Disease Is Reduced after Surgical Revascularization and Pharmacological Treatment
por: Marino, Franca, et al.
Publicado: (2013)

sRAGE and early signs of cardiac target organ damage in mild hypertensives
por: Maresca, Andrea Maria, et al.
Publicado: (2019)

Effects of high rosuvastatin doses on hepatocyte mitochondria of hypercholesterolemic mice
por: Díaz-Zagoya, Juan C., et al.
Publicado: (2021)

Soybean glycinin improves HDL-C and suppresses the effects of rosuvastatin on hypercholesterolemic rats
por: Fassini, Priscila G, et al.
Publicado: (2011)

Additive Beneficial Effects of Valsartan Combined with Rosuvastatin in the Treatment of Hypercholesterolemic Hypertensive Patients
por: Jang, Ji-Yong, et al.
Publicado: (2015)

In vitro effects of Apixaban on 5 different cancer cell lines
por: Guasti, Luigina, et al.
Publicado: (2017)

Effect of Cannabidiol on Human Peripheral Blood Mononuclear Cells and CD4+ T Cells
por: Furgiuele, Alessia, et al.
Publicado: (2023)

Erratum to: Additive Beneficial Effects of Valsartan Combined with Rosuvastatin in the Treatment of Hypercholesterolemic Hypertensive Patients
por: Jang, Ji-Yong, et al.
Publicado: (2015)

Effects of a novel cyclic RGD peptidomimetic on cell proliferation, migration and angiogenic activity in human endothelial cells
por: Fanelli, Roberto, et al.
Publicado: (2014)

Production of IL-8, VEGF and Elastase by Circulating and Intraplaque Neutrophils in Patients with Carotid Atherosclerosis
por: Marino, Franca, et al.
Publicado: (2015)

Correction: Production of IL-8, VEGF and Elastase by Circulating and Intraplaque Neutrophils in Patients with Carotid Atherosclerosis
por: Marino, Franca, et al.
Publicado: (2017)

Dopaminergic Receptors on CD4+ T Naive and Memory Lymphocytes Correlate with Motor Impairment in Patients with Parkinson’s Disease
por: Kustrimovic, Natasa, et al.
Publicado: (2016)

Statin Treatment in Hypercholesterolemic Men Does Not Attenuate Angiotensin II-Induced Venoconstriction
por: Schindler, Christoph, et al.
Publicado: (2014)

Do Th17 Lymphocytes and IL-17 Contribute to Parkinson's Disease? A Systematic Review of Available Evidence
por: Storelli, Elisa, et al.
Publicado: (2019)

Ambulatory blood pressure parameters after canrenone addition to existing treatment regimens with maximum tolerated dose of angiotensin-converting enzyme inhibitors/angiotensin II type 1 receptor blockers plus hydrochlorothiazide in uncontrolled hypertensive patients
por: Guasti, Luigina, et al.
Publicado: (2017)

Ezetimibe/Simvastatin 10/20 mg versus Rosuvastatin 10 mg in high-risk hypercholesterolemic patients stratified by prior statin treatment potency
por: Viigimaa, Margus, et al.
Publicado: (2010)

Correction: Statin Treatment in Hypercholesterolemic Men Does Not Attenuate Angiotensin II-Induced Venoconstriction
Publicado: (2014)

Parkinson’s disease patients have a complex phenotypic and functional Th1 bias: cross-sectional studies of CD4+ Th1/Th2/T17 and Treg in drug-naïve and drug-treated patients
por: Kustrimovic, Natasa, et al.
Publicado: (2018)

Management of Hypertension in the Elderly and Frail Patient
por: Guasti, Luigina, et al.
Publicado: (2022)

Pleiotropic effects of rosuvastatin on microvascular function in type 2 diabetes
por: Parson, Henri K, et al.
Publicado: (2010)

Impact of peroxisome proliferator-activated receptor γ on angiotensin II type 1 receptor-mediated insulin sensitivity, vascular inflammation and atherogenesis in hypercholesterolemic mice
por: Tiyerili, Vedat, et al.
Publicado: (2015)

Dataset of mRNA levels for dopaminergic receptors, adrenoceptors and tyrosine hydroxylase in lymphocytes from subjects with clinically isolated syndromes
por: Cosentino, Marco, et al.
Publicado: (2016)

Management of High-Risk Hypercholesterolemic Patients and PCSK9 Inhibitors Reimbursement Policies: Data from a Cohort of Italian Hypercholesterolemic Outpatients
por: Fogacci, Federica, et al.
Publicado: (2022)

Dyslipidemia in HIV-positive patients: a randomized, controlled, prospective study on ezetimibe+fenofibrate versus pravastatin monotherapy
por: Grandi, Anna M, et al.
Publicado: (2014)

Angiotensin-Induced Abdominal Aortic Aneurysms in Hypercholesterolemic Mice: Role of Serum Cholesterol and Temporal Effects of Exposure
por: Prins, Petra A., et al.
Publicado: (2014)

Manipulation of components of the renin angiotensin system in renal proximal tubules fails to alter atherosclerosis in hypercholesterolemic mice
por: Kukida, Masayoshi, et al.
Publicado: (2023)

Effects of rosuvastatin on expression of angiotensin-converting enzyme 2 after vascular balloon injury in rats
por: Li, Yong-Hong, et al.
Publicado: (2013)

Comparison of the Efficacy and Safety of Rosuvastatin/Ezetimibe Combination Therapy and Rosuvastatin Monotherapy on Lipoprotein in Patients With Type 2 Diabetes: Multicenter Randomized Controlled Study
por: Lee, Jiwoo, et al.
Publicado: (2020)

A Novel Standardized Cannabis sativa L. Extract and Its Constituent Cannabidiol Inhibit Human Polymorphonuclear Leukocyte Functions
por: Mabou Tagne, Alex, et al.
Publicado: (2019)

Efficacy of combination of Ezetimibe 10 mg and rosuvastatin 2.5 mg versus rosuvastatin 5 mg monotherapy for hypercholesterolemia in patients with type 2 diabetes
por: Torimoto, Keiichi, et al.
Publicado: (2013)

Protective Effect of Sitagliptin and Rosuvastatin Combination on Vascular Endothelial Dysfunction in Type-2 Diabetes
por: Nade, Vandana S., et al.
Publicado: (2015)

Current Perspectives on rosuvastatin
por: Hu, Miao, et al.
Publicado: (2013)

Comparison of the Efficacy of Rosuvastatin Monotherapy 20 mg with Rosuvastatin 5 mg and Ezetimibe 10 mg Combination Therapy on Lipid Parameters in Patients with Type 2 Diabetes Mellitus
por: Hwang, You-Cheol, et al.
Publicado: (2019)

Astaxanthin prevents changes in the activities of thioredoxin reductase and paraoxonase in hypercholesterolemic rabbits
por: Augusti, Paula R, et al.
Publicado: (2012)

Achievement of Lipid Targets with the Combination of Rosuvastatin and Fenofibric Acid in Patients with Type 2 Diabetes Mellitus
por: Rosenson, Robert S., et al.
Publicado: (2010)

Anti-hypercholesterolemic Effect of Berbamine Isolated from Rhizoma Coptidis in Hypercholesterolemic Zebrafish Induced by High-Cholesterol Diet
por: Han, Bing, et al.
Publicado: (2018)

Rosuvastatin and chronic hepatitis C
por: Yoshida, Eric M.
Publicado: (2011)

Rosuvastatin induced photolocalized purpura
por: Thabouti, Marwa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_u3p4ts5l162cep5l3ht3vjbdnb